| Sign In to gain access to subscriptions and/or personal tools. |
American Journal of Hospice and Palliative Medicine® 2007;24:264. A more recent version of this article appeared on September 1, 2007 © 2007 SAGE Publications
Azotemia in Cancer Patients During Inpatient Rehabilitation
Department of Palliative Care and Rehabilitation Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
* To whom correspondence should be addressed. E-mail: yguo{at}mdanderson.org.
20) and 35 (56%) in the non-azotemic group (BUN/Cr <20). Age, gender, <10 g/dL of hemoglobin, co-morbidity (diabetes mellitus and/or hypertension), discharge destiny and median rehabilitation length of stay were not significantly different in these 2 groups. Prerenal azotemia was present in a significant number of cancer patients, but it did not impact the length of rehabilitation stay or discharge destiny.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
20) and 35 (56%) in the non-azotemic group (BUN/Cr <20). Age, gender, <10 g/dL of hemoglobin, co-morbidity (diabetes mellitus and/or hypertension), discharge destiny and median rehabilitation length of stay were not significantly different in these 2 groups. Prerenal azotemia was present in a significant number of cancer patients, but it did not impact the length of rehabilitation stay or discharge destiny.